Verve Therapeutics (VERV)
(Delayed Data from NSDQ)
$6.16 USD
-0.06 (-0.96%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $6.14 -0.02 (-0.32%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/20/2024
Time: -- |
3/2024 | $-0.68 | 8.55% |
Earnings Summary
For their last quarter, Verve Therapeutics (VERV) reported earnings of -$0.69 per share, beating the Zacks Consensus Estimate of $-0.80 per share. This reflects a positive earnings surprise of 13.75%. Look out for VERV's next earnings release expected on May 20, 2024. For the next earning release, we expect the company to report earnings of -$0.68 per share, reflecting a year-over-year increase of 19.05%.
Earnings History
Price & Consensus
Zacks News for VERV
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
VERV: What are Zacks experts saying now?
Zacks Private Portfolio Services